China pharma announces receipt of noncompliance notice from nyse american

Haikou, china , june 22, 2022 /prnewswire/ -- china pharma holdings, inc. (nyse american: cphi) ("china pharma," the "company" or "we"), a specialty pharmaceutical company, today announced that on june 15, 2022, the company received a letter from nyse american llc ("nyse american" or the "exchange") stating that the company was not in compliance with the continued listing standards as set forth in section 1003(a)(iii) of the nyse american company guide (the "company guide"). in order to maintain its listing, the company must submit a plan of compliance by july 15, 2022 addressing how it intends to regain compliance with section 1003(a)(iii) of the company guide by december 15, 2023.
CPHI Ratings Summary
CPHI Quant Ranking